The clinical results so far are promising — 12 patients implanted. But this is a long regulatory road. FDA approval for broad use is years away. And the ethical questions around brain implants will only get louder.
生物科技
Neuralink
脑机接口。1,024 电极 N1 植入体。已植入 12 位以上患者。
- BCI
- Neural
- Medical Device
- Brain
- 公开报道估值
- $9.65B 私募市场估算
- 营收
- Pre-revenue 公开报道增长 N/A
- 累计融资
- $1.2B 公开报道融资
- 社区
- 1 条评论 0 人收藏
公开报道的数据仅代表特定时点,并非实时市场报价。使用前请核对来源与更新时间。
社区评论
社区如何看待 Neuralink。
来自关注这家公司的用户观点,并非经核实的公司事实。请关注其推理、证据与反方观点。
最有力的反方观点是什么?补充证据、质疑一个假设,或将 Neuralink 与可比公司联系起来。
公司概览
脑机接口。1,024 电极 N1 植入体。已植入 12 位以上患者。
核心信息
- CEO
- Elon Musk
- 成立时间
- 2016
- 总部
- Fremont, CA
- 赛道
- 生物科技
- 更新时间
- 2026年5月16日
最新新闻
追踪最新变化。
公司新闻流中有 15 篇近期报道,最新内容优先显示。

Neuralink Advances BCI Technology, Targets $1 Billion Revenue by 2031
Neuralink implants brain-computer interfaces in 21 patients and aims for significant revenue growth, pending FDA approval for commercial use.
阅读报道Neuralink's N1 Implant Enables Thought-Controlled Wheelchair Navigation
Neuralink's N1 brain implant allows 21 quadriplegic participants to control wheelchairs using their thoughts, marking a significant advancement in assistive technology.

Neuralink's N1 Implant Enables Mind-Controlled Wheelchair Navigation
Neuralink's N1 implant allows paralyzed individuals to control wheelchairs using brain signals, showcasing significant advancements in assistive technology, though it remains under FDA investigation.

Neuralink Advances Brain-Computer Interface, Enabling Wheelchair Control by Thought
Neuralink's N1 implant allows 26 trial participants with paralysis to control powered wheelchairs using their thoughts, marking a significant step toward restoring independent mobility.

Neuralink's Valuation Soars to $42 Billion After SpaceX IPO
Neuralink experiences a significant valuation increase to $42 billion, fueled by strong investor interest following the successful IPO of SpaceX.
- 01流动性
未上市公司股份并非持续交易。
- 02定价
公开报道估值并不是实时股价。
- 03信息披露
未上市公司的公开信息仍然有限。